Scientists from Chimerix, Inc. today presented in vitro data demonstrating that the company’s lipid-conjugated drugs, CMX001 and CMX157, are not substrates for the human Organic Anion Transporters (hOATs) and thus have significantly…
Tag: virus
Stratatech receives SBIR grant to develop anti-infective living human skin substitute
Stratatech Corp., a privately-held regenerative medicine company, today announced that it has been awarded a $3.5 million Fast-Track SBIR grant to expand the development of its anti-infective living human skin substitute. Stratatech…
Researchers Develop Light Technology To Combat Hospital Infections
A pioneering lighting system that can kill hospital superbugs including MRSA and C.diff has been developed by researchers at the University of Strathclyde in Glasgow. Scotland. The technology decontaminates the air and…
Salmonella Bareilly Outbreak Continues
An outbreak of Salmonella Bareilly infection associated with contaminated bean sprouts is ongoing, although fewer new cases of illness are now being recorded. The Health Protection Agency’s Centre for Infections (CFI) in…
Researchers develop new vaccine delivery system for rotavirus infection
Researchers have developed a promising new approach to vaccination for rotavirus, a common cause of severe diarrheal disease that is responsible for approximately 500,000 deaths among children in the developing world every…
NPR reports on dengue vaccine progress
NPR’s “Shots” blog examines progress in the search for a vaccine to protect against the dengue virus. WHO “estimates that 2.5 billion people worldwide are at risk of getting dengue, and most…
Australia’s Defence Against Infectious Diseases Is At Risk
The nation’s public health response capacity is at serious risk because the Australian Government has decided not to renew funding for an epidemiology program, according to an article in the Medical Journal…
NanoViricides’ optimized FluCide drug candidates reduce viral load in H1N1 influenza virus study
NanoViricides, Inc. (OTC BB: NNVC.OB) (the “Company”) reports that its optimized FluCide™ drug candidates achieved dramatic reduction in viral load within the lungs of animals infected with a lethal dose of H1N1…
Research on E.Coli bacteria could develop new vaccine for urinary infection
Urinary tract infections are a painful, recurring problem for millions of women. They are also getting more dangerous as bacteria develop resistance to the most common treatments. Scientists from the University of…
Whole Populations To Be Vaccinated In Emergency Response To Polio Outbreak
The first wave of mass polio immunization campaigns -targeting 3 million people of all ages- is to begin on Friday (12 November) to address an unusual outbreak of polio that is primarily…
Funding To Support C. difficile Research
The Peninsula Collaboration for Leadership in Applied Health Research and Care (PenCLAHRC) has provided funding to support joint research between the University of Exeter and the Royal Devon & Exeter NHS Foundation…
Contact Among Age Groups Key To Understanding Whooping Cough Spread And Control
Strategies for preventing the spread of whooping cough – on the rise in the United States and several other countries in recent years – should take into account how often people in…
Discovery on immune system pave way to develop new vaccine against pneumococcal disease
A new breakthrough in the fight against pneumonia, meningitis and septicaemia has been announced today by scientists in Leicester and Dublin. The discovery will lead to a dramatic shift in our understanding…
Aeras receives grant to develop new vaccines for TB
TB vaccine development receives a boost. The Aeras Global TB Vaccine Foundation is pleased to announce that the Netherlands Ministry of Foreign Affairs has renewed its funding to Aeras with a pledge…
PenCLAHRC provides funding to support C. difficile research
The Peninsula Collaboration for Leadership in Applied Health Research and Care (PenCLAHRC) has provided funding to support joint research between the University of Exeter and the Royal Devon & Exeter NHS Foundation…